Naveris

Waltham, MA · Founded 2017 · Privately Held (backing)

Developer of a blood test technology designed to detect specific cancer subtypes and improve patient outcomes. Naveris is based in Waltham, MA and was founded in 2017. Its last known valuation is $81.5 million. It has raised $85.5 million across 3 recorded rounds; the latest was a $17.5 million early-stage round in Jun 2024.

Last price · $/share
—
Implied valuation
$81.5M
Total raised
$85.5M
Last round
Early Stage VC
Jun 2024
How much has Naveris raised?
$85.5Macross 3 recorded rounds · Sep 2019 – Jun 2024

Most recently, Naveris raised $17.5M in its Early Stage VC (Jun 2024).

Free account
More of Naveris with a free account
  • ·Watch Naveris: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Naveris round by round

3 rounds
Jun 2024Early Stage VC$17.5MSEC filing▮
5 investors participated
Feb 2020Early Stage VC$15.4MSEC filing▮
21 investors participated
Sep 2019Seed Round$650KSEC filing▮
3 investors participated

How much has Naveris raised?

Naveris has raised $85.5 million in total; 3 of its rounds are on record, from 2019 on. The largest on record was a $650,000 seed round in Sep 2019; the most recent was a $17.5 million early-stage round in Jun 2024.

Naveris has filed 3 Form Ds with the SEC since 2019, most recently in Jul 2024 ($17.5 million sold to 5 investors).

Naveris investors

7 investors are on record for Naveris, including Ms2 Capital, BrightEdge, ABI LAB and American Cancer Society. The early-stage round in Jun 2024 drew 5 investors.

For fundraisers
Raising for a company like Naveris?

7 investors have backed Naveris.

See all 7 investors →

Frequently asked about Naveris

How much has Naveris raised?
Naveris has raised $85.5M in total across 3 recorded funding rounds.
When was Naveris's last funding round?
Naveris's most recent recorded round was Early Stage VC in Jun 2024, raising $17.5M.